Showing results (111-120 of 163) with videos related to
Sort By:
Pageof 17
European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences|February 21, 2012
Structural identifiability analysis and reparameterisation (parameter reduction) of a cardiovascular feedback modelS Y Amy Cheung, Oneeb Majid, James W T Yates, et al.Cancer Chemotherapy and Pharmacology|March 27, 2004
Population pharmacokinetic model for daunorubicin and daunorubicinol coadministered with zosuquidar.3HCl (LY335979)Sophie Callies, Dinesh P de Alwis, Atul Mehta, et al.Pharmacogenetics and Genomics|October 28, 2016
Modelling of atorvastatin pharmacokinetics and the identification of the effect of a BCRP polymorphism in the Japanese populationNikolaos Tsamandouras, Yingying Guo, Thierry Wendling, et al.The Journal of Pharmacy and Pharmacology|February 8, 2012
Comparison of in-vivo and in-silico methods used for prediction of tissue: plasma partition coefficients in ratHelen Graham, Mike Walker, Owen Jones, et al.The AAPS Journal|December 16, 2015
Deconvolution and IVIVC: Exploring the Role of Rate-Limiting ConditionsAlison Margolskee, Adam S Darwich, Aleksandra Galetin, et al.Journal of the Intensive Care Society|December 29, 2025
A prospective cohort feasibility study of real-time beta-lactam antimicrobial therapeutic drug monitoring in critically ill patients with lower respiratory infection: The TDM-TIME studyJan Hansel, Jake Lain, Emmanuel O Erhieyovwe, et al.British Journal of Clinical Pharmacology|August 24, 2017
Population pharmacokinetics of the MEK inhibitor selumetinib and its active N-desmethyl metabolite: data from 10 phase I trialsParul Patel, Eleanor Howgate, Paul Martin, et al.European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences|December 3, 2014
Analysis of the impact of controlled release formulations on oral drug absorption, gut wall metabolism and relative bioavailability of CYP3A substrates using a physiologically-based pharmacokinetic modelAndrés Olivares-Morales, Yoshiteru Kamiyama, Adam S Darwich, et al.Drug Metabolism and Disposition: the Biological Fate of Chemicals|November 2, 2010
Critique of the two-fold measure of prediction success for ratios: application for the assessment of drug-drug interactionsEleanor J Guest, Leon Aarons, J Brian Houston, et al.British Journal of Clinical Pharmacology|March 18, 2004
Retrospective population pharmacokinetic analysis of cetirizine in children aged 6 months to 12 yearsMaria Pitsiu, Ziad Hussein, Oneeb Majid, et al.Pageof 17